Pharma Mar, S.A. (BME:PHM)
Spain flag Spain · Delayed Price · Currency is EUR
66.60
-0.65 (-0.97%)
Nov 16, 2026, 5:35 PM CET

Pharma Mar Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Pharma Mar stock has a consensus rating of "Buy" and an average price target of €98.94. The average 1-year stock price forecast is 48.56% higher than the current stock price, while the lowest is €80.00 (+20.12%) and the highest is €120.00 (+80.18%).

Price Target: €98.94 (+48.56%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price€80.00€98.94€98.00€120.00
Change+20.12%+48.56%+47.15%+80.18%
* Price targets were last updated on Aug 10, 2026.

Analyst Ratings

The average analyst rating for Pharma Mar stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy665555
Buy111111
Hold222222
Sell000000
Strong Sell000000
Total998888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Chardan Capital
Chardan Capital
Buy
Maintains
€100.00
BuyMaintains€100.00+50.15%Aug 10, 2026

Financial Forecast

Revenue This Year
220.35M
from 221.39M
Decreased by -0.47%
Revenue Next Year
277.36M
from 220.35M
Increased by 25.87%
EPS This Year
2.36
from 4.30
Decreased by -45.12%
EPS Next Year
4.93
from 2.36
Increased by 108.90%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
229.83M196.34M158.15M174.86M221.39M220.35M
Revenue Growth
-14.87%-14.57%-19.45%10.56%26.61%-0.47%
Gross Profit
213.39M182.70M148.54M166.67M209.13M207.13M
Gross Margin
92.85%93.05%93.92%95.32%94.46%94.00%
Operating Income
92.45M42.07M-3.83M6.47M60.72M42.81M
Net Income
92.86M49.36M1.14M26.13M74.99M40.98M
EPS
----4.302.36
EPS Growth
----188.59%-45.12%
Forward PE
12.7616.7467.7636.2924.0328.22
Dividend / Share
0.650.650.650.801.001.02
Dividend Growth
8.33%--23.08%25.00%1.75%
Free Cash Flow
----43.75M37.91M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High234.0M
Avg220.3M
Low200.1M

Revenue Growth

Revenue Growth202620272028
High
5.7%
Avg
-0.5%
Low
-9.6%

EPS Forecast

EPS202620272028
High3.03
Avg2.36
Low1.91

EPS Growth

EPS Growth202620272028
High
-29.5%
Avg
-45.1%
Low
-55.6%